VST Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 12, 2025, 1:35 pm

Quick Insight

VST Industries Ltd, a prominent player in the cigarettes and tobacco products industry, currently trades at ₹282 with a market cap of ₹4,784 Cr. The stock's P/E stands at 22.7, indicating a moderate valuation, while ROE and ROCE at 16.5% and 20.8% respectively reflect healthy profitability and efficiency. With a strong OPM of 26% and a net profit of ₹290 Cr, the company demonstrates robust operational performance. The shareholding pattern reveals significant promoter holding at 32.16%, with institutional investors and the public holding substantial stakes. VST's healthy reserves of ₹1,153 Cr and zero borrowings indicate a strong financial position. However, the P/BV ratio of 3.37x suggests the stock may be slightly overvalued. Overall, VST Industries presents a compelling investment opportunity given its solid financial standing and market position, although investors should remain cautious of its valuation levels.

Competitors of VST Industries Ltd

All Competitor Stocks of VST Industries Ltd

Quarterly Result

Last Updated: August 1, 2025, 9:15 am

Below is a detailed analysis of the quarterly data for VST Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 298.00 Cr.. The value appears to be declining and may need further review. It has decreased from 349.00 Cr. (Mar 2025) to 298.00 Cr., marking a decrease of 51.00 Cr..
• For Expenses, as of Jun 2025, the value is 221.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 280.00 Cr. (Mar 2025) to 221.00 Cr., marking a decrease of 59.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 77.00 Cr.. The value appears strong and on an upward trend. It has increased from 70.00 Cr. (Mar 2025) to 77.00 Cr., marking an increase of 7.00 Cr..
• For OPM %, as of Jun 2025, the value is 26.00%. The value appears strong and on an upward trend. It has increased from 20.00% (Mar 2025) to 26.00%, marking an increase of 6.00%.
• For Other Income, as of Jun 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2025) to 11.00 Cr., marking an increase of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Depreciation, as of Jun 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 12.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 76.00 Cr.. The value appears strong and on an upward trend. It has increased from 67.00 Cr. (Mar 2025) to 76.00 Cr., marking an increase of 9.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 21.00% (Mar 2025) to 26.00%, marking an increase of 5.00%.
• For Net Profit, as of Jun 2025, the value is 56.00 Cr.. The value appears strong and on an upward trend. It has increased from 53.00 Cr. (Mar 2025) to 56.00 Cr., marking an increase of 3.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 3.30. The value appears strong and on an upward trend. It has increased from 3.12 (Mar 2025) to 3.30, marking an increase of 0.18.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 2:44 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 2:04 pm

Below is a detailed analysis of the balance sheet data for VST Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 170.00 Cr.. The value appears strong and on an upward trend. It has increased from 15.00 Cr. (Mar 2024) to 170.00 Cr., marking an increase of 155.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,153.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,237.00 Cr. (Mar 2024) to 1,153.00 Cr., marking a decrease of 84.00 Cr..
• For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 493.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 468.00 Cr. (Mar 2024) to 493.00 Cr., marking an increase of 25.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,816.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,720.00 Cr. (Mar 2024) to 1,816.00 Cr., marking an increase of 96.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 307.00 Cr.. The value appears strong and on an upward trend. It has increased from 268.00 Cr. (Mar 2024) to 307.00 Cr., marking an increase of 39.00 Cr..
• For CWIP, as of Mar 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 47.00 Cr. (Mar 2024) to 1.00 Cr., marking a decrease of 46.00 Cr..
• For Investments, as of Mar 2025, the value is 532.00 Cr.. The value appears strong and on an upward trend. It has increased from 447.00 Cr. (Mar 2024) to 532.00 Cr., marking an increase of 85.00 Cr..
• For Other Assets, as of Mar 2025, the value is 976.00 Cr.. The value appears strong and on an upward trend. It has increased from 958.00 Cr. (Mar 2024) to 976.00 Cr., marking an increase of 18.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,816.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,720.00 Cr. (Mar 2024) to 1,816.00 Cr., marking an increase of 96.00 Cr..

Notably, the Reserves (1,153.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for VST Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 17.10. This value is within the healthy range. It has decreased from 195.29 (Mar 24) to 17.10, marking a decrease of 178.19.
• For Diluted EPS (Rs.), as of Mar 25, the value is 17.10. This value is within the healthy range. It has decreased from 195.29 (Mar 24) to 17.10, marking a decrease of 178.19.
• For Cash EPS (Rs.), as of Mar 25, the value is 19.72. This value is within the healthy range. It has decreased from 219.97 (Mar 24) to 19.72, marking a decrease of 200.25.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 77.87. It has decreased from 811.05 (Mar 24) to 77.87, marking a decrease of 733.18.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 77.87. It has decreased from 811.05 (Mar 24) to 77.87, marking a decrease of 733.18.
• For Dividend / Share (Rs.), as of Mar 25, the value is 10.00. This value exceeds the healthy maximum of 3. It has decreased from 150.00 (Mar 24) to 10.00, marking a decrease of 140.00.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 82.29. It has decreased from 919.88 (Mar 24) to 82.29, marking a decrease of 837.59.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 18.46. This value is within the healthy range. It has decreased from 280.28 (Mar 24) to 18.46, marking a decrease of 261.82.
• For PBIT / Share (Rs.), as of Mar 25, the value is 15.84. This value is within the healthy range. It has decreased from 255.60 (Mar 24) to 15.84, marking a decrease of 239.76.
• For PBT / Share (Rs.), as of Mar 25, the value is 21.76. This value is within the healthy range. It has decreased from 255.60 (Mar 24) to 21.76, marking a decrease of 233.84.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 17.10. This value is within the healthy range. It has decreased from 195.29 (Mar 24) to 17.10, marking a decrease of 178.19.
• For PBDIT Margin (%), as of Mar 25, the value is 22.43. This value is within the healthy range. It has decreased from 30.46 (Mar 24) to 22.43, marking a decrease of 8.03.
• For PBIT Margin (%), as of Mar 25, the value is 19.25. This value is within the healthy range. It has decreased from 27.78 (Mar 24) to 19.25, marking a decrease of 8.53.
• For PBT Margin (%), as of Mar 25, the value is 26.44. This value is within the healthy range. It has decreased from 27.78 (Mar 24) to 26.44, marking a decrease of 1.34.
• For Net Profit Margin (%), as of Mar 25, the value is 20.77. This value exceeds the healthy maximum of 10. It has decreased from 21.22 (Mar 24) to 20.77, marking a decrease of 0.45.
• For Return on Networth / Equity (%), as of Mar 25, the value is 21.95. This value is within the healthy range. It has decreased from 24.07 (Mar 24) to 21.95, marking a decrease of 2.12.
• For Return on Capital Employeed (%), as of Mar 25, the value is 19.99. This value is within the healthy range. It has decreased from 30.97 (Mar 24) to 19.99, marking a decrease of 10.98.
• For Return On Assets (%), as of Mar 25, the value is 15.99. This value is within the healthy range. It has decreased from 17.53 (Mar 24) to 15.99, marking a decrease of 1.54.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.79. It has decreased from 0.84 (Mar 24) to 0.79, marking a decrease of 0.05.
• For Current Ratio (X), as of Mar 25, the value is 2.74. This value is within the healthy range. It has increased from 2.66 (Mar 24) to 2.74, marking an increase of 0.08.
• For Quick Ratio (X), as of Mar 25, the value is 1.71. This value is within the healthy range. It has increased from 1.64 (Mar 24) to 1.71, marking an increase of 0.07.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.67. This value is below the healthy minimum of 4. It has decreased from 1.95 (Mar 24) to 1.67, marking a decrease of 0.28.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 76.52 (Mar 24) to 0.00, marking a decrease of 76.52.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 67.93 (Mar 24) to 0.00, marking a decrease of 67.93.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 23.48 (Mar 24) to 0.00, marking a decrease of 23.48.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 32.07 (Mar 24) to 0.00, marking a decrease of 32.07.
• For Enterprise Value (Cr.), as of Mar 25, the value is 4,437.88. It has decreased from 5,479.92 (Mar 24) to 4,437.88, marking a decrease of 1,042.04.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.17. This value exceeds the healthy maximum of 3. It has decreased from 3.86 (Mar 24) to 3.17, marking a decrease of 0.69.
• For EV / EBITDA (X), as of Mar 25, the value is 14.15. This value is within the healthy range. It has increased from 12.66 (Mar 24) to 14.15, marking an increase of 1.49.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.19. This value exceeds the healthy maximum of 3. It has decreased from 3.88 (Mar 24) to 3.19, marking a decrease of 0.69.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 23.47 (Mar 24) to 0.00, marking a decrease of 23.47.
• For Price / BV (X), as of Mar 25, the value is 3.37. This value exceeds the healthy maximum of 3. It has decreased from 4.40 (Mar 24) to 3.37, marking a decrease of 1.03.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.19. This value exceeds the healthy maximum of 3. It has decreased from 3.88 (Mar 24) to 3.19, marking a decrease of 0.69.
• For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has increased from 0.05 (Mar 24) to 0.06, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness